D. Aghion and . Stein, Academic freedom, private-sector focus, and the process of innovation, RAND Journal of Economics, vol.39, issue.3, pp.617-635, 2008.

. Billette-de-villemeur, One Lab, Two Firms, Many Possibilities: On R&D Outsourcing in the Biopharmaceutical Industry, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02107357

. Broad, Billionaires with big ideas are privatizing American science, 2014.

C. Cour-des, La sécurité sociale. Rapport sur l'application des lois de financement de la sécurité sociale, 2017.

M. Gonzalez, . Stadler, and . Perez-castrillo, Private versus Social Incentives for Pharmaceutical Innovation, Journal of Health Economics, vol.50, pp.286-297, 2016.

. Jelovac, On the relationship between negotiated prices of pharmaceuticals and the patients' co-payment, Economics Bulletin, vol.35, issue.1, pp.481-493, 2015.

V. Maraninci, L'urgence de maîtriser les prix des nouveaux medicaments contre le cancer, pp.16-19, 2016.

, Medicare Prescription Drug Price Negotiation Act of 2017, pp.115-2017